GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 7/27/2026 4:51:59 PM | Micro | View | Financials | 10-K | SEC | Y 2026 ending: 4/30/2026 | Rev: $59,425,000 +4.4% | Assets $26,989,000 | EPS -$0.08 | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 7/27/2026 4:34:30 PM | View | Financials | Earnings | SEC | Y 2026 | Rev $13,835,000 +12.0% | Assets $26,989,000 | EPS -$0.04 | Export Earnings Model | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 3/12/2026 5:01:25 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2026 ending: 1/31/2026 | Rev: $16,559,000 -2.8% | Assets $28,447,000 | EPS -$0.02 | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 3/12/2026 4:25:05 PM | View | Financials | Earnings | SEC | 3Q 2026 | Rev $16,559,000 -2.8% | Assets $28,447,000 | EPS -$0.02 | Export Earnings Model | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 12/15/2025 5:03:05 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2026 ending: 10/31/2025 | Rev: $15,035,000 +11.5% | Assets $30,162,000 | EPS $0.02 | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 12/15/2025 4:16:15 PM | View | Financials | Earnings | SEC | 2Q 2026 | Rev $15,035,000 +11.5% | Assets $30,162,000 | EPS $0.02 | Export Earnings Model | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 9/15/2025 5:04:16 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2026 ending: 7/31/2025 | Rev: $13,995,000 -0.5% | Assets $30,546,000 | EPS -$0.03 | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 9/15/2025 4:48:34 PM | View | Financials | Earnings | SEC | 1Q 2026 | Rev $13,995,000 -0.5% | Assets $30,546,000 | EPS -$0.03 | Export Earnings Model | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 8/22/2025 3:21:19 PM | View | Proxy | SEC | Y 2025 | ||||||
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 7/23/2025 5:15:25 PM | Micro | View | Financials | 10-K | SEC | Y 2025 ending: 4/30/2025 | Rev: $56,944,000 +13.5% | Assets $32,344,000 | EPS $0.33 | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 7/23/2025 4:12:37 PM | View | Financials | Earnings | SEC | Y 2025 | Rev $12,355,000 -11.8% | Assets $32,344,000 | EPS -$0.13 | Export Earnings Model | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 3/17/2025 11:12:12 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2025 ending: 1/31/2025 | Rev: $17,039,000 +41.8% | Assets $30,627,000 | EPS $0.31 | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 3/11/2025 4:33:30 PM | View | Financials | Earnings | SEC | 3Q 2025 | Rev $17,039,000 +41.8% | Assets $30,627,000 | EPS $0.31 | Export Earnings Model | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 12/16/2024 4:34:39 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2025 ending: 10/31/2024 | Rev: $13,489,000 +16.6% | Assets $25,240,000 | EPS $0.05 | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 12/11/2024 4:41:43 PM | View | Financials | Earnings | SEC | 2Q 2025 | Rev $13,489,000 +16.6% | Assets $25,240,000 | EPS $0.05 | Export Earnings Model | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 9/13/2024 1:23:47 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2025 ending: 7/31/2024 | Rev: $14,061,000 +11.9% | Assets $24,933,000 | EPS $0.09 | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 9/11/2024 4:34:48 PM | View | Financials | Earnings | SEC | 1Q 2025 | Rev $14,061,000 +11.9% | Assets $24,933,000 | EPS $0.09 | Export Earnings Model | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 8/27/2024 4:35:19 PM | View | Proxy | SEC | Y 2024 | ||||||
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 7/19/2024 4:49:47 PM | Micro | View | Financials | 10-K | SEC | Y 2024 ending: 4/30/2024 | Rev: $50,155,000 -6.9% | Assets $26,132,000 | EPS -$0.54 | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 7/18/2024 4:15:13 PM | View | Financials | Earnings | SEC | Y 2024 | Rev $14,002,000 +7.1% | Assets $26,132,000 | EPS -$0.01 | Export Earnings Model | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 3/15/2024 6:19:24 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2024 ending: 1/31/2024 | Rev: $12,019,000 -5.9% | Assets $26,787,000 | EPS -$0.19 | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 3/12/2024 4:33:04 PM | View | Financials | Earnings | SEC | 3Q 2024 | Rev $12,019,000 -5.9% | Assets $26,787,000 | EPS -$0.19 | Export Earnings Model | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 12/13/2023 4:55:11 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2024 ending: 10/31/2023 | Rev: $11,573,000 -19.0% | Assets $28,294,000 | EPS -$0.15 | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 12/12/2023 4:16:04 PM | View | Financials | Earnings | SEC | 2Q 2024 | Rev $11,573,000 -19.0% | Assets $28,294,000 | EPS -$0.15 | Export Earnings Model | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 9/13/2023 5:29:13 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2024 ending: 7/31/2023 | Rev: $12,561,000 -8.6% | Assets $29,906,000 | EPS -$0.19 | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 9/13/2023 4:01:54 PM | View | Financials | Earnings | SEC | 1Q 2024 | Rev $12,561,000 -8.6% | Assets $29,906,000 | EPS -$0.19 | Export Earnings Model | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 8/28/2023 3:13:33 PM | View | Proxy | SEC | Y 2023 | ||||||
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 7/24/2023 4:28:42 PM | Micro | View | Financials | 10-K | SEC | Y 2023 ending: 4/30/2023 | Rev: $53,870,000 +9.7% | Assets $34,311,000 | EPS -$0.39 | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 7/24/2023 4:05:38 PM | View | Financials | Earnings | SEC | Y 2023 | Rev $13,071,000 +1.5% | Assets $34,311,000 | EPS -$0.19 | Export Earnings Model | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 3/16/2023 2:17:25 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2023 ending: 1/31/2023 | Rev: $12,773,000 -3.2% | Assets $36,151,000 | EPS -$0.18 | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 3/15/2023 4:00:31 PM | View | Financials | Earnings | SEC | 3Q 2023 | Rev $12,773,000 -3.2% | Assets $36,151,000 | EPS -$0.18 | Export Earnings Model | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 12/13/2022 4:49:37 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2023 ending: 10/31/2022 | Rev: $14,281,000 +21.2% | Assets $36,364,000 | ||
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 12/13/2022 4:02:32 PM | View | Financials | Earnings | SEC | 2Q 2023 | Rev $14,281,000 +21.2% | Assets $36,364,000 | Export Earnings Model | ||
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 9/12/2022 5:09:21 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2023 ending: 7/31/2022 | Rev: $13,745,000 +22.1% | Assets $34,390,000 | EPS -$0.02 | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 9/8/2022 4:00:07 PM | View | Financials | Earnings | SEC | 1Q 2023 | Rev $13,745,000 +22.1% | Assets $34,390,000 | EPS -$0.02 | Export Earnings Model | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 8/31/2022 9:29:53 AM | View | Proxy | SEC | Y 2022 | ||||||
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 8/29/2022 3:20:09 PM | View | Proxy | SEC | Y 2022 | ||||||
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 8/29/2022 3:17:37 PM | View | Proxy | SEC | Y 2022 | ||||||
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 7/22/2022 4:35:50 PM | Micro | View | Financials | 10-K | SEC | Y 2022 ending: 4/30/2022 | Rev: $49,109,000 +19.7% | Assets $35,378,000 | EPS $0.04 | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 7/21/2022 4:00:02 PM | View | Financials | Earnings | SEC | Y 2022 | Rev $12,877,000 +21.9% | Assets $35,378,000 | EPS -$0.02 | Export Earnings Model | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 3/15/2022 5:21:50 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2022 ending: 1/31/2022 | Rev: $13,193,000 +22.0% | Assets $33,584,000 | EPS $0.05 | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 3/15/2022 4:32:23 PM | View | Financials | Earnings | SEC | 3Q 2022 | Rev $13,193,000 +22.0% | Assets $33,584,000 | EPS $0.05 | Export Earnings Model | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 12/13/2021 5:14:58 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2022 ending: 10/31/2021 | Rev: $11,786,000 +16.5% | Assets $29,296,000 | EPS $0.02 | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 12/13/2021 4:00:46 PM | View | Financials | Earnings | SEC | 2Q 2022 | Rev $11,786,000 +16.5% | Assets $29,296,000 | EPS $0.02 | Export Earnings Model | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 9/13/2021 5:12:19 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2022 ending: 7/31/2021 | Rev: $11,253,000 +17.9% | Assets $28,108,000 | EPS -$0.01 | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 9/13/2021 4:19:34 PM | View | Financials | Earnings | SEC | 1Q 2022 | Rev $11,253,000 +17.9% | Assets $28,108,000 | EPS -$0.01 | Export Earnings Model | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 8/30/2021 5:08:49 PM | View | Proxy | SEC | Y 2021 | ||||||
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 7/26/2021 5:33:07 PM | Micro | View | Financials | 10-K | SEC | Y 2021 ending: 4/30/2021 | Rev: $41,040,000 +27.8% | Assets $27,591,000 | EPS $0.02 | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 7/22/2021 8:16:37 AM | View | Financials | Earnings | SEC | Y 2021 | Rev $10,564,000 +20.8% | Assets $27,591,000 | EPS -$0.05 | Export Earnings Model | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 3/15/2021 3:25:48 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2021 ending: 1/31/2021 | Rev: $10,812,000 +20.0% | Assets $25,260,000 | EPS $0.07 | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 3/11/2021 4:03:06 PM | View | Financials | Earnings | SEC | 3Q 2021 | Rev $10,812,000 +20.0% | Assets $25,260,000 | EPS $0.07 | Export Earnings Model | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 12/14/2020 5:24:41 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2021 ending: 10/31/2020 | Rev: $10,117,000 +32.7% | Assets $25,760,000 | ||
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 12/14/2020 4:02:08 PM | View | Financials | Earnings | SEC | 2Q 2021 | Rev $10,117,000 +32.7% | Assets $25,760,000 | Export Earnings Model | ||
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 9/14/2020 4:52:08 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2021 ending: 7/31/2020 | Rev: $9,547,000 +41.7% | Assets $22,820,000 | EPS $0.01 | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 9/14/2020 4:01:24 PM | View | Financials | Earnings | SEC | 1Q 2021 | Rev $9,547,000 +41.7% | Assets $22,820,000 | EPS $0.01 | Export Earnings Model | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 9/11/2020 6:03:09 AM | View | Proxy | SEC | Y 2020 | ||||||
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 8/28/2020 4:19:05 PM | View | Proxy | SEC | Y 2020 | ||||||
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 7/28/2020 5:35:47 PM | Micro | View | Financials | 10-K | SEC | Y 2020 ending: 4/30/2020 | Rev: $32,123,000 +18.7% | Assets $20,751,000 | EPS -$0.18 | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 7/27/2020 4:33:42 PM | View | Financials | Earnings | SEC | Y 2020 | Rev $8,748,000 +13.3% | Assets $20,751,000 | EPS -$0.19 | Export Earnings Model | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 3/16/2020 4:43:12 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2020 ending: 1/31/2020 | Rev: $9,012,000 +40.2% | Assets $15,075,000 | EPS $0.03 | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 3/12/2020 4:07:43 PM | View | Financials | Earnings | SEC | 3Q 2020 | Rev $9,012,000 +40.2% | Assets $15,075,000 | EPS $0.03 | Export Earnings Model | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 12/16/2019 5:05:59 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2020 ending: 10/31/2019 | Rev: $7,625,000 +13.9% | Assets $13,947,000 | EPS $0.02 | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 12/16/2019 4:16:21 PM | View | Financials | Earnings | SEC | 2Q 2020 | Rev $7,625,000 +13.9% | Assets $13,947,000 | EPS $0.02 | Export Earnings Model | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 9/16/2019 5:21:10 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2020 ending: 7/31/2019 | Rev: $6,737,000 +8.2% | Assets $13,362,000 | EPS -$0.06 | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 9/16/2019 4:05:08 PM | View | Financials | Earnings | SEC | 1Q 2020 | Rev $6,737,000 +8.2% | Assets $13,362,000 | EPS -$0.06 | Export Earnings Model | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 8/28/2019 4:41:55 PM | View | Proxy | SEC | Y 2019 | ||||||
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 7/29/2019 4:56:46 PM | Micro | View | Financials | 10-K | SEC | Y 2019 ending: 4/30/2019 | Rev: $27,067,000 +33.7% | Assets $11,265,000 | EPS $0.01 | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 7/15/2019 4:36:28 PM | View | Financials | Earnings | SEC | Y 2019 | Rev $7,719,000 +56.8% | Assets $11,265,000 | EPS -$0.02 | Export Earnings Model | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 3/18/2019 5:16:48 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2019 ending: 1/31/2019 | Rev: $6,430,000 +26.5% | Assets $10,911,000 | EPS -$0.03 | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 3/18/2019 4:23:20 PM | View | Financials | Earnings | SEC | 3Q 2019 | Rev $6,430,000 +26.5% | Assets $10,911,000 | EPS -$0.03 | Export Earnings Model | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 12/17/2018 5:02:51 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2019 ending: 10/31/2018 | Rev: $6,693,000 +28.6% | Assets $10,239,000 | EPS $0.02 | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 12/17/2018 4:25:28 PM | View | Financials | Earnings | SEC | 2Q 2019 | Rev $6,693,000 +28.6% | Assets $10,239,000 | EPS $0.02 | Export Earnings Model | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 9/14/2018 4:26:12 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2019 ending: 7/31/2018 | Rev: $6,225,000 +23.7% | Assets $8,391,000 | EPS $0.04 | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 9/13/2018 4:06:59 PM | View | Financials | Earnings | SEC | 1Q 2019 | Rev $6,225,000 +23.7% | Assets $8,391,000 | EPS $0.04 | Export Earnings Model | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 8/28/2018 4:12:50 PM | View | Proxy | SEC | Y 2018 | ||||||
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 7/30/2018 5:28:06 PM | Micro | View | Financials | 10-K | SEC | Y 2018 ending: 4/30/2018 | Rev: $20,241,000 +31.3% | Assets $8,078,000 | EPS -$0.13 | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 7/26/2018 4:02:39 PM | View | Financials | Earnings | SEC | Y 2018 | Rev $4,922,000 +32.3% | Assets $8,078,000 | EPS -$0.05 | Export Earnings Model | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 3/19/2018 4:36:02 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2018 ending: 1/31/2018 | Rev: $5,082,000 +42.6% | Assets $7,095,000 | EPS -$0.01 | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 3/15/2018 3:59:55 PM | View | Financials | Earnings | SEC | 3Q 2018 | Rev $5,082,000 +42.6% | Assets $7,095,000 | EPS -$0.01 | Export Earnings Model | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 12/15/2017 12:17:30 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2018 ending: 10/31/2017 | Rev: $5,203,000 +16.7% | Assets $6,493,000 | EPS -$0.01 | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 12/7/2017 4:20:11 PM | View | Financials | Earnings | SEC | 2Q 2018 | Rev $5,203,000 +16.7% | Assets $6,493,000 | EPS -$0.01 | Export Earnings Model | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 9/14/2017 5:32:14 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2018 ending: 7/31/2017 | Rev: $5,033,000 +37.1% | Assets $6,467,000 | EPS -$0.06 | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 9/14/2017 4:32:41 PM | View | Financials | Earnings | SEC | 1Q 2018 | Rev $5,033,000 +37.1% | Assets $6,467,000 | EPS -$0.06 | Export Earnings Model | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 8/31/2017 5:30:23 PM | View | Proxy | SEC | Y 2017 | ||||||
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 8/28/2017 5:19:40 PM | View | Proxy | SEC | Y 2017 | ||||||
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 7/28/2017 4:07:51 PM | Micro | View | Financials | 10-K | SEC | Y 2017 ending: 4/30/2017 | Rev: $15,411,000 +37.8% | Assets $8,011,000 | EPS -$0.64 | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 7/27/2017 3:58:11 PM | View | Financials | Earnings | SEC | Y 2017 | Rev $3,720,000 +31.1% | Assets $8,011,000 | EPS -$0.20 | Export Earnings Model | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 3/17/2017 1:54:13 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2017 ending: 1/31/2017 | Rev: $3,565,000 +39.7% | Assets $7,546,000 | EPS -$0.13 | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 3/16/2017 4:02:21 PM | View | Financials | Earnings | SEC | 3Q 2017 | Rev $3,565,000 +39.7% | Assets $7,546,000 | EPS -$0.13 | Export Earnings Model | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 12/14/2016 4:05:20 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2017 ending: 10/31/2016 | Rev: $4,457,000 +50.0% | Assets $8,044,000 | EPS -$0.05 | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 11/29/2016 4:15:19 PM | View | Financials | Earnings | SEC | 2Q 2017 | Rev $4,457,000 +50.0% | Assets $8,044,000 | EPS -$0.05 | Export Earnings Model | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 9/14/2016 3:07:13 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2017 ending: 7/31/2016 | Rev: $3,670,000 +30.0% | Assets $7,849,000 | EPS -$0.26 | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 9/9/2016 8:15:09 AM | View | Financials | Earnings | SEC | 1Q 2017 | Rev $3,670,000 +30.0% | Assets $7,849,000 | EPS -$0.26 | Export Earnings Model | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 8/25/2016 1:51:46 PM | View | Proxy | SEC | Y 2016 | ||||||
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 7/29/2016 1:09:21 PM | Micro | View | Financials | 10-K | SEC | Y 2016 ending: 4/30/2016 | Rev: $11,182,000 +26.2% | Assets $5,777,000 | EPS -$1.20 | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 3/16/2016 10:01:15 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2016 ending: 1/31/2016 | Rev: $2,552,000 +39.5% | Assets $7,145,000 | EPS -$0.28 | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 3/15/2016 8:30:31 AM | View | Financials | Earnings | SEC | 3Q 2016 | Rev $2,552,000 +39.5% | Assets $7,145,000 | EPS -$0.28 | Export Earnings Model | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 12/15/2015 5:21:20 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2016 ending: 10/31/2015 | Rev: $2,971,000 +57.9% | Assets $7,582,000 | EPS -$0.29 | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 12/14/2015 4:34:18 PM | View | Financials | Earnings | SEC | 2Q 2016 | Rev $2,971,000 +57.9% | Assets $7,582,000 | EPS -$0.29 | Export Earnings Model | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 9/11/2015 4:02:21 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2016 ending: 7/31/2015 | Rev: $2,822,000 +47.6% | Assets $9,848,000 | EPS -$0.33 | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 9/10/2015 4:00:45 PM | View | Financials | Earnings | SEC | 1Q 2016 | Rev $2,822,000 +47.6% | Assets $9,848,000 | EPS -$0.33 | Export Earnings Model | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 9/1/2015 5:08:55 PM | View | Proxy | SEC | Y 2015 | ||||||
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 8/28/2015 5:08:11 PM | View | Proxy | SEC | Y 2015 | ||||||
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 7/29/2015 4:09:30 PM | Micro | View | Financials | 10-K | SEC | Y 2015 ending: 4/30/2015 | Rev: $8,863,000 -23.3% | Assets $12,047,000 | EPS -$2.20 | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 7/28/2015 8:30:24 AM | View | Financials | Earnings | SEC | Y 2015 | Rev $3,241,000 +31.9% | Assets $12,047,000 | EPS -$0.26 | Export Earnings Model | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 3/30/2015 5:15:38 PM | View | Proxy | SEC | Y 2014 | ||||||
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 3/17/2015 5:25:55 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2015 ending: 1/31/2015 | Rev: $1,829,000 -50.4% | Assets $2,833,000 | EPS -$0.61 | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 3/17/2015 9:00:20 AM | View | Financials | Earnings | SEC | 3Q 2015 | Rev $1,829,000 -50.4% | Assets $2,833,000 | EPS -$0.61 | Export Earnings Model | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 12/15/2014 8:33:15 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2015 ending: 10/31/2014 | Rev: $1,882,000 -21.0% | Assets $3,311,000 | EPS -$0.65 | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 12/12/2014 8:30:12 AM | View | Financials | Earnings | SEC | 2Q 2015 | Rev $1,882,000 -21.0% | Assets $3,311,000 | EPS -$0.65 | Export Earnings Model | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 9/12/2014 4:01:50 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2015 ending: 7/31/2014 | Rev: $1,912,000 -36.7% | Assets $5,678,000 | EPS -$0.64 | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 9/11/2014 4:00:44 PM | View | Financials | Earnings | SEC | 1Q 2015 | Rev $1,912,000 -36.7% | Assets $5,678,000 | EPS -$0.64 | Export Earnings Model | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 8/28/2014 4:05:28 PM | View | Proxy | SEC | Y 2014 | ||||||
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 7/28/2014 4:38:06 PM | Micro | View | Financials | 10-K | SEC | Y 2014 ending: 4/30/2014 | Rev: $11,550,000 +38.8% | Assets $8,867,000 | EPS -$1.33 | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 7/24/2014 4:00:34 PM | View | Financials | Earnings | SEC | Y 2014 | Rev $2,458,000 +33.4% | Assets $8,867,000 | EPS -$1.25 | Export Earnings Model | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 3/14/2014 5:01:30 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2014 ending: 1/31/2014 | Rev: $3,690,000 +26.5% | Assets $10,471,000 | EPS -$0.02 | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 3/13/2014 4:02:49 PM | View | Financials | Earnings | SEC | 3Q 2014 | Rev $3,690,000 +26.5% | Assets $10,471,000 | EPS -$0.02 | Export Earnings Model | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 12/13/2013 8:01:03 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2014 ending: 10/31/2013 | Rev: $2,383,000 +63.4% | Assets $10,502,000 | EPS -$0.03 | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 12/12/2013 4:02:09 PM | View | Financials | Earnings | SEC | 2Q 2014 | Rev $2,383,000 +63.4% | Assets $10,502,000 | EPS -$0.03 | Export Earnings Model | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 9/13/2013 4:01:33 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2014 ending: 7/31/2013 | Rev: $3,020,000 +43.4% | Assets $10,670,000 | EPS -$0.03 | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 9/13/2013 8:19:28 AM | View | Financials | Earnings | SEC | 1Q 2014 | Rev $3,020,000 +43.4% | Assets $10,670,000 | EPS -$0.03 | Export Earnings Model | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 8/26/2013 6:15:27 PM | View | Proxy | SEC | Y 2013 | ||||||
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 7/26/2013 4:03:02 PM | Micro | View | Financials | 10-K | SEC | Y 2013 ending: 4/30/2013 | Rev: $8,323,000 +16.4% | Assets $11,651,000 | EPS -$0.12 | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 6/11/2013 9:03:06 PM | View | Financials | Earnings | SEC | Y 2013 | Rev $1,842,000 +33.4% | Assets $11,651,000 | EPS -$0.03 | Export Earnings Model | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 3/14/2013 7:00:32 AM | View | Financials | Earnings | SEC | 3Q 2013 | Rev $2,917,000 +21.7% | Assets $13,012,000 | EPS -$0.02 | Export Earnings Model | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 3/13/2013 4:20:53 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2013 ending: 1/31/2013 | Rev: $2,917,000 +21.7% | Assets $13,012,000 | EPS -$0.02 | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 12/13/2012 2:52:43 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2013 ending: 10/31/2012 | Rev: $1,458,000 -16.3% | Assets $4,225,000 | EPS -$0.04 | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 9/12/2012 2:46:10 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2013 ending: 7/31/2012 | Rev: $2,106,000 +28.9% | Assets $5,145,000 | EPS -$0.03 | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 7/18/2012 5:16:00 PM | Micro | View | Financials | 10-K | SEC | Y 2012 ending: 4/30/2012 | Rev: $7,149,000 +3.9% | Assets $6,922,000 | EPS -$0.19 | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 3/14/2012 2:58:50 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2012 ending: 1/31/2012 | Rev: $2,396,000 -14.6% | Assets $8,865,000 | EPS -$0.04 | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 12/14/2011 2:49:10 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2012 ending: 10/31/2011 | Rev: $1,741,000 +86.6% | Assets $9,872,000 | EPS -$0.05 | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | 9/13/2011 2:08:59 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2012 ending: 7/31/2011 | Rev: $1,634,000 +2.1% | Assets $11,801,000 | EPS -$0.04 | |
| CHAMPIONS BIOTECHNOLOGY, INC. (CSBR) | 3/7/2011 2:38:48 PM | View | Proxy | SEC | Y 2010 | ||||||
| CHAMPIONS BIOTECHNOLOGY, INC. (CSBR) | 12/13/2010 5:29:26 PM | View | Financials | Earnings | SEC | 2Q 2011 | Rev $933,000 | Export Earnings Model | |||
| CHAMPIONS BIOTECHNOLOGY, INC. (CSBR) | 9/10/2010 4:05:50 PM | View | Financials | Earnings | SEC | 1Q 2011 | Rev $1,600,000 | EPS -$0.02 | Export Earnings Model | ||
| CHAMPIONS BIOTECHNOLOGY, INC. (CSBR) | 7/28/2010 4:05:15 PM | View | Financials | Earnings | SEC | Y 2010 | Export Earnings Model | ||||
| CHAMPIONS BIOTECHNOLOGY, INC. (CSBR) | 3/17/2010 4:02:54 PM | View | Financials | Earnings | SEC | 3Q 2010 | Export Earnings Model | ||||
| CHAMPIONS BIOTECHNOLOGY, INC. (CSBR) | 12/16/2009 4:05:03 PM | View | Financials | Earnings | SEC | 2Q 2010 | Export Earnings Model | ||||
| CHAMPIONS BIOTECHNOLOGY, INC. (CSBR) | 9/17/2009 7:15:20 PM | View | Financials | Earnings | SEC | 1Q 2010 | Export Earnings Model | ||||
| CHAMPIONS BIOTECHNOLOGY, INC. (CSBR) | 3/18/2009 5:01:59 PM | View | Financials | Earnings | SEC | 3Q 2009 | Export Earnings Model |